BSE Live
Apr 17, 16:01Prev. Close
306.00
Open Price
314.90
Bid Price (Qty.)
0.00 (0)
Offer Price (Qty.)
0.00 (0)
NSE Live
Apr 17, 15:52Prev. Close
306.15
Open Price
306.15
Bid Price (Qty.)
0.00 (0)
Offer Price (Qty.)
307.40 (14532)
| Balance Sheet of Advanced Enzyme Technologies (in Rs. Cr.) | Mar 25 | Mar 24 | Mar 23 | Mar 22 | Mar 21 | |
| 12 mths | 12 mths | 12 mths | 12 mths | 12 mths | ||
| EQUITIES AND LIABILITIES | ||||||
| SHAREHOLDER'S FUNDS | ||||||
| Equity Share Capital | 22.38 | 22.37 | 22.37 | 22.36 | 22.35 | |
| Total Share Capital | 22.38 | 22.37 | 22.37 | 22.36 | 22.35 | |
| Reserves and Surplus | 606.97 | 558.11 | 502.97 | 457.35 | 410.48 | |
| Total Reserves and Surplus | 606.97 | 558.11 | 502.97 | 457.35 | 410.48 | |
| Total Shareholders Funds | 629.34 | 580.47 | 525.33 | 480.35 | 435.45 | |
| NON-CURRENT LIABILITIES | ||||||
| Long Term Borrowings | 0.00 | 0.00 | 0.00 | 0.00 | 0.18 | |
| Deferred Tax Liabilities [Net] | 11.80 | 10.69 | 11.81 | 11.15 | 11.60 | |
| Other Long Term Liabilities | 1.97 | 1.09 | 1.45 | 0.95 | 0.00 | |
| Long Term Provisions | 0.82 | 0.66 | 0.32 | 0.86 | 0.99 | |
| Total Non-Current Liabilities | 14.59 | 12.45 | 13.57 | 12.96 | 12.77 | |
| CURRENT LIABILITIES | ||||||
| Short Term Borrowings | 0.00 | 0.00 | 0.01 | 0.18 | 0.14 | |
| Trade Payables | 22.68 | 21.72 | 18.13 | 20.26 | 22.53 | |
| Other Current Liabilities | 18.49 | 15.75 | 16.77 | 13.82 | 16.32 | |
| Short Term Provisions | 3.54 | 2.54 | 1.99 | 2.06 | 2.05 | |
| Total Current Liabilities | 44.70 | 40.01 | 36.90 | 36.31 | 41.04 | |
| Total Capital And Liabilities | 688.63 | 632.93 | 575.80 | 529.62 | 489.25 | |
| ASSETS | ||||||
| NON-CURRENT ASSETS | ||||||
| Tangible Assets | 150.88 | 141.82 | 142.45 | 131.54 | 129.83 | |
| Intangible Assets | 5.62 | 0.31 | 0.41 | 0.49 | 1.20 | |
| Capital Work-In-Progress | 20.74 | 16.45 | 5.61 | 3.25 | 1.96 | |
| Other Assets | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Fixed Assets | 177.25 | 163.99 | 153.88 | 140.71 | 138.37 | |
| Non-Current Investments | 253.71 | 205.49 | 185.48 | 172.68 | 151.56 | |
| Deferred Tax Assets [Net] | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Long Term Loans And Advances | 0.07 | 0.04 | 33.34 | 24.35 | 28.85 | |
| Other Non-Current Assets | 25.40 | 15.08 | 13.95 | 15.19 | 10.19 | |
| Total Non-Current Assets | 456.43 | 384.59 | 386.66 | 352.94 | 328.97 | |
| CURRENT ASSETS | ||||||
| Current Investments | 36.65 | 50.80 | 15.99 | 16.68 | 32.93 | |
| Inventories | 101.45 | 96.88 | 76.79 | 80.08 | 63.42 | |
| Trade Receivables | 78.17 | 75.17 | 66.67 | 49.09 | 54.74 | |
| Cash And Cash Equivalents | 5.83 | 18.57 | 24.72 | 17.98 | 1.87 | |
| Short Term Loans And Advances | 0.03 | 0.04 | 0.04 | 5.80 | 0.03 | |
| OtherCurrentAssets | 10.07 | 6.87 | 4.93 | 7.07 | 7.29 | |
| Total Current Assets | 232.20 | 248.34 | 189.14 | 176.69 | 160.28 | |
| Total Assets | 688.63 | 632.93 | 575.80 | 529.62 | 489.25 | |
| OTHER ADDITIONAL INFORMATION | ||||||
| CONTINGENT LIABILITIES, COMMITMENTS | ||||||
| Contingent Liabilities | 19.98 | 17.73 | 13.69 | 8.64 | 11.60 | |
| CIF VALUE OF IMPORTS | ||||||
| Raw Materials | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Stores, Spares And Loose Tools | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Trade/Other Goods | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Capital Goods | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| EXPENDITURE IN FOREIGN EXCHANGE | ||||||
| Expenditure In Foreign Currency | 70.48 | 59.44 | 42.00 | 43.46 | 29.75 | |
| REMITTANCES IN FOREIGN CURRENCIES FOR DIVIDENDS | ||||||
| Dividend Remittance In Foreign Currency | -- | -- | -- | -- | -- | |
| EARNINGS IN FOREIGN EXCHANGE | ||||||
| FOB Value Of Goods | 120.44 | 109.66 | 93.75 | 73.59 | 64.81 | |
| Other Earnings | -- | -- | -- | -- | -- | |
| BONUS DETAILS | ||||||
| Bonus Equity Share Capital | 15.55 | 15.55 | 15.55 | 15.55 | 15.55 | |
| NON-CURRENT INVESTMENTS | ||||||
| Non-Current Investments Quoted Market Value | -- | -- | -- | -- | -- | |
| Non-Current Investments Unquoted Book Value | 0.06 | 0.06 | 0.06 | 0.06 | 0.06 | |
| CURRENT INVESTMENTS | ||||||
| Current Investments Quoted Market Value | 36.65 | 50.80 | 15.99 | 16.68 | -- | |
| Current Investments Unquoted Book Value | -- | -- | -- | -- | -- |
03.02.2026
Advanced Enzyme Consolidated December 2025 Net Sales at Rs 171.95 crore, up 1.68% Y-o-Y
03.02.2026
Advanced Enzyme Standalone December 2025 Net Sales at Rs 95.58 crore, down 5.24% Y-o-Y
19.11.2025
Advanced Enzyme Consolidated September 2025 Net Sales at Rs 184.53 crore, up 26.31% Y-o-Y
13.11.2025
Advanced Enzyme Standalone September 2025 Net Sales at Rs 115.75 crore, up 49.59% Y-o-Y
03.02.2026
Advanced Enzyme Consolidated December 2025 Net Sales at Rs 171.95 crore, up 1.68% Y-o-Y
03.02.2026
Advanced Enzyme Standalone December 2025 Net Sales at Rs 95.58 crore, down 5.24% Y-o-Y
19.11.2025
Advanced Enzyme Consolidated September 2025 Net Sales at Rs 184.53 crore, up 26.31% Y-o-Y
13.11.2025
Advanced Enzyme Standalone September 2025 Net Sales at Rs 115.75 crore, up 49.59% Y-o-Y
13.04.2026
13.04.2026
10.04.2026
09.04.2026
21.01.2026
Dr Reddy's posts smaller-than-expected Q3 profit fall on domestic boost
12.11.2025
07.11.2025
24.10.2025
Dr Reddy's Q2 Results: Net profit rises 7% to Rs 1,347 crore, misses estimates
17.07.2025
Sun Pharma Q1 PAT seen up 8.4% YoY to Rs 3,132.7 cr: ICICI Securities
17.07.2025
Biocon Q1 PAT may dip 72% YoY to Rs 91.1 cr: ICICI Securities
17.07.2025
Cipla Q1 PAT seen up 2% YoY to Rs 1,246.7 cr: ICICI Securities
29.01.2025
Sun Pharma Q3 Preview: Double-digit India, US sales to power mid-teen profit growth